newly diagnosed type 2 diabetes patients hemoglobin A1C insulin based therapy dual oral hypoglycemic diabetes patients
Conditions
Interventions
Patients taking metformin 1000 mg once daily plus intermediate acting insulin (NPH) 0.1 unit per kg at bedtime ,Patients taking metformin 1000 mg plus glipizide 5 mg or pioglitazone 15 mg or sitaglipt
Treatment,Treatment
insulin based therapy,dual oral hypoglycemia agents
Sponsors
Lampang hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1.newly diagnosed type 2 diabetes patients 2.patients with very high hemoglobin A1C (greater than or equal to nine percent) 3.patients with eGFR greater than or equal 45 mL
Exclusion criteria
Exclusion criteria: 1.two types of hyperglycemic emergencies: diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome 2.The patient is pregnant or breastfeeding 3.Patients with hemoglobinopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare the ratio of patients with hemoglobin A1C less than or equal to seven percent within 24 weeks after treatment in newly diagnosed type 2 diabetes patients with very high hemoglobin A1C At baseline FBS HbA1C UA UACR SMBG BUN Cr electrolyte CBC CXR EKG 12 leads | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare the ratio of patients with hemoglobin A1C less than or equal to seven percent within 1 year after treatment in newly diagnosed type 2 diabetes patients with very high hemoglobin A1C At baseline FBS HbA1C UA UACR SMBG BUN Cr electrolyte CBC CXR EKG 12 leads | — |
Countries
Thailand
Contacts
Public ContactNuttaya Wachiraphansakul
Department of internal medicine, Lampang hospital
Outcome results
None listed